150 related articles for article (PubMed ID: 9821415)
1. Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration.
Heuck C; Wolthers OD; Kollerup G; Hansen M; Teisner B
J Pediatr; 1998 Nov; 133(5):608-12. PubMed ID: 9821415
[TBL] [Abstract][Full Text] [Related]
2. Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide.
Heuck C; Wolthers OD; Hansen M; Kollerup G
Steroids; 1997 Oct; 62(10):659-64. PubMed ID: 9381513
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?
Schou AJ; Heuck C; Wolthers OD
Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide.
Wolthers OD; Juul A; Hansen M; Müller J; Pedersen S
Acta Paediatr; 1995 Apr; 84(4):393-7. PubMed ID: 7540898
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.
Heuck C; Heickendorff L; Wolthers OD
Arch Dis Child; 2000 Oct; 83(4):334-9. PubMed ID: 10999872
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma.
Herjavecz I; Blomqvist P; Serrano A
Respir Med; 1999 Apr; 93(4):230-5. PubMed ID: 10464886
[TBL] [Abstract][Full Text] [Related]
7. Short stature never killed anybody.
Brook CG
J Pediatr; 1998 Nov; 133(5):591-2. PubMed ID: 9821412
[No Abstract] [Full Text] [Related]
8. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
Pauwels RA; Pedersen S; Busse WW; Tan WC; Chen YZ; Ohlsson SV; Ullman A; Lamm CJ; O'Byrne PM;
Lancet; 2003 Mar; 361(9363):1071-6. PubMed ID: 12672309
[TBL] [Abstract][Full Text] [Related]
9. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.
Birkebaek NH; Esberg G; Andersen K; Wolthers O; Hassager C
Arch Dis Child; 1995 Dec; 73(6):524-7. PubMed ID: 8546510
[TBL] [Abstract][Full Text] [Related]
10. [Longitudinal growth in children with asthma treated with inhaled glucocorticoids].
Gradman J; Wolthers OD
Ugeskr Laeger; 2006 Feb; 168(9):885-9. PubMed ID: 16513049
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma.
Möller C; Strömberg L; Oldaeus G; Arweström E; Kjellman M
Pediatr Pulmonol; 1999 Nov; 28(5):337-43. PubMed ID: 10536064
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
Gradman J; Wolthers OD
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635
[TBL] [Abstract][Full Text] [Related]
16. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
[TBL] [Abstract][Full Text] [Related]
17. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma.
Jónasson G; Carlsen KH; Jonasson C; Mowinckel P
Allergy; 2000 Aug; 55(8):740-8. PubMed ID: 10955700
[TBL] [Abstract][Full Text] [Related]
18. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.
Weiner P; Weiner M; Azgad Y
Thorax; 1995 Dec; 50(12):1270-3. PubMed ID: 8553300
[TBL] [Abstract][Full Text] [Related]
19. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
Shapiro G; Bronsky EA; LaForce CF; Mendelson L; Pearlman D; Schwartz RH; Szefler SJ
J Pediatr; 1998 Jun; 132(6):976-82. PubMed ID: 9627589
[TBL] [Abstract][Full Text] [Related]
20. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
